Novo Nordisk

Novo Nordisk Limited is the UK commercial and medical affiliate of Novo Nordisk A/S, the Danish pharmaceutical company focused on diabetes, obesity, and cardiometabolic disease.

The UK operation covers commercialisation, medical affairs, and clinical trial activities.

Separately, Novo Nordisk Research Centre Oxford (NNRCO) is a dedicated target discovery unit embedded at the University of Oxford's Old Road Campus, employing around 100 researchers in computational biology, genetics, and disease biology focused on cardiometabolic drug targets.